Swiss drugmaker will make a gene-based Covid-19 vaccine being developed by researchers at Massachusetts Eye and Ear hospital, Massachusetts General Hospital and the University of Pennsylvania
Novartis AG has agreed to manufacture a gene-based coronavirus vaccine being developed by scientists at Massachusetts Eye and Ear hospital, Massachusetts General and the University of Pennsylvania, paving the way for human testing to begin later this year.
The Swiss drugmaker’s gene therapy unit AveXis is already making test batches of the vaccine and plans to start producing doses later in the summer that can be used for a clinical trial, said Dave Lennon, the unit’s president.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Stock market live Tuesday: Dow surges 500, JPM jumps on Dimon comment, China worries ruin the close“We’ve widened the gap between large and small” businesses under coronavirus lockdowns, Wharton’s Jeremy Siegel said yesterday. “It was almost a capitalist dream.”
続きを読む »
L.A. County will ask state to allow restaurants, other businesses to reopen soonerL.A. County supervisors say the county has made enough progress in dealing with the coronavirus that they will ask the state to allow more establishments to begin reopening.
続きを読む »
Defense secretary says coronavirus vaccine will be available within months, but experts skepticalPentagon leaders expressed strong confidence Thursday that a coronavirus vaccine will be available by January, and possibly as early as this fall — claims that were met with skepticism by scientific experts.
続きを読む »
‘Vaccine Nationalism’: A New Dynamic in the Race to Quash CoronavirusPharmaceutical companies are bracing for export bans on future coronavirus vaccines and spreading production across different continents, on early signs of a geopolitical scramble to secure supplies.
続きを読む »
Treasury yields edge lower as US-China tensions cool investor optimismU.S. government debt prices inched higher Wednesday morning as U.S. concerns on new Hong Kong security laws cooled investor sentiment over economic reopening and a possible coronavirus vaccine.
続きを読む »